These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 7714976

  • 41. A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy--can we predict adverse pathological outcomes?
    Thong AE, Shikanov S, Katz MH, Gofrit ON, Eggener S, Zagaja GP, Shalhav AL, Zorn KC.
    J Urol; 2008 Dec; 180(6):2436-40. PubMed ID: 18930486
    [Abstract] [Full Text] [Related]

  • 42. Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
    Veltri RW, Miller MC, Mangold LA, O'Dowd GJ, Epstein JI, Partin AW.
    J Urol; 2002 Jul; 168(1):100-4. PubMed ID: 12050500
    [Abstract] [Full Text] [Related]

  • 43. Minute focus of prostate cancer on needle biopsy: correlation with radical prostatectomy specimen.
    Montanari E, Del Nero A, Gazzano G, Mangiarotti B, Bernardini P, Longo F, Cordima G, Itri E.
    Arch Ital Urol Androl; 2009 Mar; 81(1):9-12. PubMed ID: 19499751
    [Abstract] [Full Text] [Related]

  • 44. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
    Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O'Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD.
    Cancer; 2003 Apr 15; 97(8):1884-93. PubMed ID: 12673714
    [Abstract] [Full Text] [Related]

  • 45. Pathological features after radical prostatectomy in potential candidates for active monitoring.
    Griffin CR, Yu X, Loeb S, Desireddi VN, Han M, Graif T, Catalona WJ.
    J Urol; 2007 Sep 15; 178(3 Pt 1):860-3; discussion 863. PubMed ID: 17631347
    [Abstract] [Full Text] [Related]

  • 46. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
    Abdollah F, Scattoni V, Raber M, Roscigno M, Briganti A, Suardi N, Gallina A, Capitanio U, Freschi M, Salonia A, Cestari A, Guazzoni G, Rigatti P, Montorsi F.
    BJU Int; 2011 Aug 15; 108(3):366-71. PubMed ID: 21087451
    [Abstract] [Full Text] [Related]

  • 47. Initial atypical diagnosis with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy.
    Chen YB, Pierorazio PM, Epstein JI.
    J Urol; 2010 Nov 15; 184(5):1953-7. PubMed ID: 20846684
    [Abstract] [Full Text] [Related]

  • 48. [Incidental prostate cancer: volume, location and degree of differentiation of the tumor in the radical prostatectomy specimen and value of subclassification to stage A1 and A2].
    Voges GE, McNeal JE, Stamey TA.
    Urologe A; 1991 Nov 15; 30(6):401-9. PubMed ID: 1722922
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
    Epstein JI, Walsh PC, Carmichael M, Brendler CB.
    JAMA; 1994 Feb 02; 271(5):368-74. PubMed ID: 7506797
    [Abstract] [Full Text] [Related]

  • 51. Preoperative prediction of pathologically insignificant prostate cancer in radical prostatectomy specimens: the role of prostate volume and the number of positive cores.
    Raventós CX, Orsola A, de Torres I, Cecchini L, Trilla E, Planas J, Morote J.
    Urol Int; 2010 Feb 02; 84(2):153-8. PubMed ID: 20215818
    [Abstract] [Full Text] [Related]

  • 52. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.
    Robinson BD, Epstein JI.
    J Urol; 2010 Oct 02; 184(4):1328-33. PubMed ID: 20723921
    [Abstract] [Full Text] [Related]

  • 53. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.
    Falzarano SM, Zhou M, Hernandez AV, Moussa AS, Jones JS, Magi-Galluzzi C.
    Urology; 2010 Sep 02; 76(3):682-7. PubMed ID: 20206973
    [Abstract] [Full Text] [Related]

  • 54. Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density.
    Allan RW, Sanderson H, Epstein JI.
    J Urol; 2003 Aug 02; 170(2 Pt 1):370-2. PubMed ID: 12853777
    [Abstract] [Full Text] [Related]

  • 55. Is a single focus of low-grade prostate cancer diagnosed on saturation biopsy predictive of clinically insignificant cancer?
    Pepe P, Fraggetta F, Galia A, Candiano G, Grasso G, Aragona F.
    Urol Int; 2010 Aug 02; 84(4):440-4. PubMed ID: 20234121
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.
    Villa L, Capitanio U, Briganti A, Abdollah F, Suardi N, Salonia A, Gallina A, Freschi M, Russo A, Castiglione F, Bianchi M, Rigatti P, Montorsi F, Scattoni V.
    J Urol; 2013 Mar 02; 189(3):854-9. PubMed ID: 23022004
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. 'Insignificant' prostate cancer on prostatectomy and cystoprostatectomy: variation on a theme 'low-volume/low-grade' prostate cancer?
    Trpkov K, Yilmaz A, Bismar TA, Montironi R.
    BJU Int; 2010 Aug 02; 106(3):304-15. PubMed ID: 20653654
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.